Clinical application: Restoration of immune homeostasis by autophagy as a potential therapeutic target in sepsis (Review)

Experimental and Therapeutic Medicine

Volumn 11, Issue 4, 2016, Pages 1159-1167

  Zhang, Lemeng ^a   Ai, Yuhang ^a   Tsung, Allan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Immunosuppression; Sepsis

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BECLIN 1; BECLIN 2; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; INTERFERON; INTERLEUKIN 1BETA; TARGET OF RAPAMYCIN KINASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; APOPTOSIS; AUTOPHAGY; B LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; DENDRITIC CELL; DISEASE COURSE; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE; NONHUMAN; PROTEIN INTERACTION; PULMONARY HYPERTENSION; REVIEW; SEPSIS; T LYMPHOCYTE; UPREGULATION;

EID: 84958777155     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2016.3071     Document Type: Review

References (95)

1. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG and Karl IE: Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27: 1230-1251, 1999.
2. Aneja R and Fink MP: Promising therapeutic agents for sepsis. Trends Microbiol 15: 31-37, 2007.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J and Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303-1310, 2001.
4. Angus DC and van der Poll T: Severe sepsis and septic shock. N Engl J Med 369: 840-851, 2013.
5. Ziegler EJ, Fisher CJ Jr., Sprung CL, Straube RC, Sadoff JC, Foulke GE, Wortel CH, Fink MP, Dellinger RP, Teng NN, et al: Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group. N Engl J Med 324: 429-436, 1991.
6. Fisher CJ Jr., Slotman GJ, Opal SM, Pribble JP, Bone RC, Emmanuel G, Ng D, Bloedow DC and Catalano MA; IL-1RA Sepsis Syndrome Study Group: Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: A randomized, open-label, placebo-controlled multicenter trial. Crit Care Med 22: 12-21, 1994.
7. Fisher CJ Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM and Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor: Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334: 1697-1702, 1996.
8. Boomer JS, Green JM and Hotchkiss RS: The changing immune system in sepsis: Is individualized immuno-modulatory therapy the answer? Virulence 5: 45-56, 2014.
9. Zhang L, Cardinal JS, Bahar R, Evankovich J, Huang H, Nace G, Billiar TR, Rosengart MR, Pan P and Tsung A: Interferon regulatory factor-1 regulates the autophagic response in LPS-stimulated macrophages through nitric oxide. Mol Med 18: 201-208, 2012.
10. Zhang L, Cardinal JS, Pan P, Rosborough BR, Chang Y, Yan W, Huang H, Billiar TR, Rosengart MR and Tsung A: Splenocyte apoptosis and autophagy is mediated by interferon regulatory factor 1 during murine endotoxemia. Shock 37: 511-517, 2012.
11. Hotchkiss RS and Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 348: 138-150, 2003.
12. Hotchkiss RS and Nicholson DW: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6: 813-822, 2006.
13. Venet F, Chung CS, Monneret G, Huang X, Horner B, Garber M and Ayala A: Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83: 523-535, 2008.
14. Delano MJ, Scumpia PO, Weinstein JS, Coco D, Nagaraj S, Kelly-Scumpia KM, O'Malley KA, Wynn JL, Antonenko S, Al-Quran SZ, et al: MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis. J Exp Med 204: 1463-1474, 2007.
15. Osuchowski MF, Welch K, Siddiqui J and Remick DG: Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J Immunol 177: 1967-1974, 2006.
16. Adib Conquy M and Cavaillon J M: C omp en sat or y anti-inflammatory response syndrome. Thromb Haemost 101: 36-47, 2009.
17. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr., Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG and Karl IE: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166: 6952-6963, 2001.
18. Hotchkiss RS, Tinsley KW, Swanson PE, Grayson MH, Osborne DF, Wagner TH, Cobb JP, Coopersmith C and Karl IE: Depletion of dendritic cells, but not macrophages, in patients with sepsis. J Immunol 168: 2493-2500, 2002.
19. Stearns-Kurosawa DJ, Osuchowski MF, Valentine C, Kurosawa S and Remick DG: The pathogenesis of sepsis. Annu Rev Pathol 6: 19-48, 2011.
20. Levine B and Yuan J: Autophagy in cell death: An innocent convict? J Clin Invest 115: 2679-2688, 2005.
21. Nakahira K, Haspel JA, Rathinam VA, Lee SJ, Dolinay T, Lam HC, Englert JA, Rabinovitch M, Cernadas M, Kim HP, et al: Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12: 222-230, 2011.
22. Carchman EH, Rao J, Loughran PA, Rosengart MR and Zuckerbraun BS: Heme oxygenase-1-mediated autophagy protects against hepatocyte cell death and hepatic injury from infection/sepsis in mice. Hepatology 53: 2053-2062, 2011.
23. Takahashi W, Watanabe E, Fujimura L, Watanabe-Takano H, Yoshidome H, Swanson PE, Tokuhisa T, Oda S and Hatano M: Kinetics and protective role of autophagy in a mouse cecal ligation and puncture-induced sepsis. Crit Care 17: R160, 2013.
24. Hsiao HW, Tsai KL, Wang LF, Chen YH, Chiang PC, Chuang SM and Hsu C: The decline of autophagy contributes to proximal tubular dysfunction during sepsis. Shock 37: 289-296, 2012.
25. Howell GM, Gomez H, Collage RD, Loughran P, Zhang X, Escobar DA, Billiar TR, Zuckerbraun BS and Rosengart MR: Augmenting autophagy to treat acute kidney injury during endo- toxemia in mice. PLoS One 8: e69520, 2013.
26. Lo S, Yuan SS, Hsu C, Cheng YJ, Chang YF, Hsueh HW, Lee PH and Hsieh YC: Lc3 over-expression improves survival and attenuates lung injury through increasing autophagosomal clearance in septic mice. Ann Surg 257: 352-363, 2013.
27. Yen YT, Yang HR, Lo HC, Hsieh YC, Tsai SC, Hong CW and Hsieh CH: Enhancing autophagy with activated protein C and rapamycin protects against sepsis-induced acute lung injury. Surgery 153: 689-698, 2013.
28. Hsieh YC, Athar M and Chaudry IH: When apoptosis meets autophagy: Deciding cell fate after trauma and sepsis. Trends Mol Med 15: 129-138, 2009.
29. Hengartner MO: The biochemistry of apoptosis. Nature 407: 770-776, 2000.
30. Budihardjo I, Oliver H, Lutter M, Luo X and Wang X: Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 15: 269-290, 1999.
31. Hotch k iss RS, Osmon SB, Cha ng KC, Wag ner T H, Coopersmith CM and Karl IE: Accelerated lymphocyte death in sepsis occurs by both the death receptor and mitochondrial pathways. J Immunol 174: 5110-5118, 2005.
32. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD II, Kreisel D, Krupnick AS, et al: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306: 2594-2605, 2011.
33. Wesche DE, Lomas-Neira JL, Perl M, Chung CS and Ayala A: Leukocyte apoptosis and its significance in sepsis and shock. J Leukoc Biol 78: 325-337, 2005.
34. Felmet KA, Hall MW, Clark RS, Jaffe R and Carcillo JA: Prolonged lymphopenia, lymphoid depletion, and hypoprolac-tinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174: 3765-3772, 2005.
35. Hotchkiss RS, Chang KC, Grayson MH, Tinsley KW, Dunne BS, Davis CG, Osborne DF and Karl IE: Adoptive transfer of apoptotic splenocytes worsens survival, whereas adoptive transfer of necrotic splenocytes improves survival in sepsis. Proc Natl Acad Sci USA 100: 6724-6729, 2003.
36. Wesche-Soldato DE, Swan RZ, Chung CS and Ayala A: The apoptotic pathway as a therapeutic target in sepsis. Curr Drug Targets 8: 493-500, 2007.
37. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827-872, 1995.
38. Hotchkiss RS, Tinsley KW, Swanson PE, Chang KC, Cobb JP, Buchman TG, Korsmeyer SJ and Karl IE: Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci USA 96: 14541-14546, 1999.
39. Hotchkiss RS, Chang KC, Swanson PE, Tinsley KW, Hui JJ, Klender P, Xanthoudakis S, Roy S, Black C, Grimm E, et al: Caspase inhibitors improve survival in sepsis: A critical role of the lymphocyte. Nat Immunol 1: 496-501, 2000.
40. Dong X, Shen K and Bulow HE: Intrinsic and extrinsic mechanisms of dendritic morphogenesis. Annu Rev Physiol 77: 271-300, 2015.
41. Gautier EL, Huby T, Saint-Charles F, Ouzilleau B, Chapman MJ and Lesnik P: Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock. J Immunol 180: 6941-6946, 2008.
42. Tinsley KW, Grayson MH, Swanson PE, Drewry AM, Chang KC, Karl IE and Hotchkiss RS: Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells. J Immunol 171: 909-914, 2003.
43. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH and Ayala A: In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 106: 2295-2301, 2005.
44. Brahmamdam P, Watanabe E, Unsinger J, Chang KC, Schierding W, Hoekzema AS, Zhou TT, McDonough JS, Holemon H, Heidel JD, et al: Targeted delivery of siRNA to cell death proteins in sepsis. Shock 32: 131-139, 2009.
45. Lamkanfi M, Moreira LO, Makena P, Spierings DC, Boyd K, Murray PJ, Green DR and Kanneganti TD: Caspase-7 deficiency protects from endotoxin-induced lymphocyte apoptosis and improves survival. Blood 113: 2742-2745, 2009.
46. Hotchkiss RS, Swanson PE, Knudson CM, Chang KC, Cobb JP, Osborne DF, Zollner KM, Buchman TG, Korsmeyer SJ and Karl IE: Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis. J Immunol 162: 4148-4156, 1999.
47. Peck-Palmer OM, Unsinger J, Chang KC, McDonough JS, Perlman H, McDunn JE and Hotchkiss RS: Modulation of the Bcl-2 family blocks sepsis-induced depletion of dendritic cells and macrophages. Shock 31: 359-366, 2009.
48. Chung CS, Song GY, Lomas J, Simms HH, Chaudry IH and Ayala A: Inhibition of Fas/Fas ligand signaling improves septic survival: Differential effects on macrophage apoptotic and func- tional capacity. J Leukoc Biol 74: 344-351, 2003.
49. Méthot N, Huang J, Coulombe N, Vaillancourt JP, Rasper D, Tam J, Han Y, Colucci J, Zamboni R, Xanthoudakis S, et al: Differential efficacy of caspase inhibitors on apoptosis markers during sepsis in rats and implication for fractional inhibition requirements for therapeutics. J Exp Med 199: 199-207, 2004.
50. Kidd VJ: Proteolytic activities that mediate apoptosis. Annu Rev Physiol 60: 533-573, 1998.
51. Martinon F and Tschopp J: Inflammatory caspases: Linking an intracellular innate immune system to autoinflammatory diseases. Cell 117: 561-574, 2004.
52. Parrino J, Hotchkiss RS and Bray M: Prevention of immune cell apoptosis as potential therapeutic strategy for severe infections. Emerg Infect Dis 13: 191-198, 2007.
53. Levine B, Mizushima N and Virgin HW: Autophagy in immunity and inflammation. Nature 469: 323-335, 2011.
54. Klionsky DJ and Codogno P: The mechanism and physiological function of macroautophagy. J Innate Immun 5: 427-433, 2013.
55. He C and Klionsky DJ: Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93, 2009.
56. Jung CH, Ro SH, Cao J, Otto NM and Kim DH: mTOR regulation of autophagy. FEBS Lett 584: 1287-1295, 2010.
57. Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD and Levine B: Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122: 927-939, 2005.
58. Nishida Y, Arakawa S, Fujitani K, Yamaguchi H, Mizuta T, Kanaseki T, Komatsu M, Otsu K, Tsujimoto Y and Shimizu S: Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 461: 654-658, 2009.
59. Behrends C, Sowa ME, Gygi SP and Harper JW: Network organization of the human autophagy system. Nature 466: 68-76, 2010.
60. Moy RH and Cherry S: Antimicrobial autophagy: A conserved innate immune response in Drosophila. J Innate Immun 5: 444-455, 2013.
61. Levine B and Kroemer G: Autophagy in the pathogenesis of disease. Cell 132: 27-42, 2008.
62. Pua HH, Guo J, Komatsu M and He YW: Autophagy is essential for mitochondrial clearance in mature T lymphocytes. J Immunol 182: 4046-4055, 2009.
63. Miller BC, Zhao Z, Stephenson LM, Cadwell K, Pua HH, Lee HK, Mizushima NN, Iwasaki A, He YW, Swat W and Virgin HW IV: The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4: 309-314, 2008.
64. Pua HH, Dzhagalov I, Chuck M, Mizushima N and He YW: A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J Exp Med 204: 25-31, 2007.
65. Lee HK, Mattei LM, Steinberg BE, Alberts P, Lee YH, Chervonsky A, Mizushima N, Grinstein S and Iwasaki A: In vivo requirement for Atg5 in antigen presentation by dendritic cells. Immunity 32: 227-239, 2010.
66. Pyle A, Burn DJ, Gordon C, Swan C, Chinnery PF and Baudouin SV: Fall in circulating mononuclear cell mitochondrial DNA content in human sepsis. Intensive Care Med 36: 956-962, 2010.
67. Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K and Hauser CJ: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464: 104-107, 2010.
68. Dupont N, Jiang S, Pilli M, Ornatowski W, Bhattacharya D and Deretic V: Autophagy-based unconventional secretory pathway for extracellular delivery of IL-β. EMBO J 30: 4701-4711, 2011.
69. Jiang S, Dupont N, Castillo EF and Deretic V: Secretory versus degradative autophagy: Unconventional secretion of inflammatory mediators. J Innate Immun 5: 471-479, 2013.
70. Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C and Levine B: Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128: 931-946, 2007.
71. Tal MC, Sasai M, Lee HK, Yordy B, Shadel GS and Iwasaki A: Absence of autophagy results in reactive oxygen species-dependent amplification of RLR signaling. Proc Natl Acad Sci USA 106: 2770-2775, 2009.
72. Maiuri MC, Zalckvar E, Kimchi A and Kroemer G: Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol 8: 741-752, 2007.
73. Fimia GM and Piacentini M: Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci 67: 1581-1588, 2010.
74. Rubinstein AD and Kimchi A: Life in the balance-a mechanistic view of the crosstalk between autophagy and apoptosis. J Cell Sci 125: 5259-5268, 2012.
75. Zinkel S, Gross A and Yang E: BCL2 family in DNA damage and cell cycle control. Cell Death Differ 13: 1351-1359, 2006.
76. Shi CS and Kehrl JH: MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J Biol Chem 283: 33175-33182, 2008.
77. Kurihara Y, Kanki T, Aoki Y, Hirota Y, Saigusa T, Uchiumi T and Kang D: Mitophagy plays an essential role in reducing mitochondrial production of reactive oxygen species and mutation of mitochondrial DNA by maintaining mitochondrial quantity and quality in yeast. J Biol Chem 287: 3265-3272, 2012.
78. Zhou R, Yazdi AS, Menu P and Tschopp J: A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.
79. Tang D, Loze MT, Zeh HJ and Kang R: The redox protein HMGB1 regulates cell death and survival in cancer treatment. Autophagy 6: 1181-1183, 2010.
80. Yousefi S, Perozzo R, Schmid I, Ziemiecki A, Schaffner T, Scapozza L, Brunner T and Simon HU: Calpain-mediated cleavage of Atg5 switches autophagy to apoptosis. Nat Cell Biol 8: 1124-1132, 2006.
81. Pyo JO, Jang MH, Kwon YK, Lee HJ, Jun JI, Woo HN, Cho DH, Choi B, Lee H, Kim JH, et al: Essential roles of Atg5 and FADD in autophagic cell death: Dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem 280: 20722-20729, 2005.
82. González-Polo RA, Boya P, Pauleau AL, Jalil A, Larochette N, Souquère S, Eskelinen EL, Pierron G, Saftig P and Kroemer G: The apoptosis/autophagy paradox: Autophagic vacuolization before apoptotic death. J Cell Sci 118: 3091-3102, 2005.
83. Mizumura K, Cloonan SM, Haspel JA and Choi AM: The emerging importance of autophagy in pulmonary diseases. Chest 142: 1289-1299, 2012.
84. Mizumura K, Choi AM and Ryter SW: Emerging role of selective autophagy in human diseases. Front Pharmacol 5: 244, 2014.
85. Lam KK, Zheng X, Forestieri R, Balgi AD, Nodwell M, Vollett S, Anderson HJ, Andersen RJ, Av-Gay Y and Roberge M: Nitazoxanide stimulates autophagy and inhibits mTORC1 signaling and intracellular proliferation of Mycobacterium tuberculosis. PLoS Pathog 8: e1002691, 2012.
86. Tung SM, Unal C, Ley A, Pena C, Tunggal B, Noegel AA, Krut O, Steinert M and Eichinger L: Loss of Dictyostelium ATG9 results in a pleiotropic phenotype affecting growth, development, phagocytosis and clearance and replication of Legionella pneumophila. Cell Microbiol 12: 765-780, 2010.
87. Ye Y, Li X, Wang W, Ouedraogo KC, Li Y, Gan C, Tan S, Zhou X and Wu M: Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice. Am J Physiol Lung Cell Mol Physiol 307: L355-L363, 2014.
88. Gannagé M, Dormann D, Albrecht R, Dengjel J, Torossi T, Rämer PC, Lee M, Strowig T, Arrey F, Conenello G, et al: Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6: 367-380, 2009.
89. Lee SJ, Smith A, Guo L, Alastalo TP, Li M, Sawada H, Liu X, Chen ZH, Ifedigbo E, Jin Y, et al: Autophagic protein LC3B confers resistance against hypoxia-induced pulmonary hypertension. Am J Respir Crit Care Med 183: 649-658, 2011.
90. Patel AS, Lin L, Geyer A, Haspel JA, An CH, Cao J, Rosas IO and Morse D: Autophagy in idiopathic pulmonary fibrosis. PLoS One 7: e41394, 2012.
91. Chen ZH, Kim HP, Sciurba FC, Lee SJ, Feghali-Bostwick C, Stolz DB, Dhir R, Landreneau RJ, Schuchert MJ, Yousem SA, et al: Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS One 3: e3316, 2008.
92. Chen ZH, Lam HC, Jin Y, Kim HP, Cao J, Lee SJ, Ifedigbo E, Parameswaran H, Ryter SW and Choi AM: Autophagy protein microtubule-associated protein 1 light chain-3B (LC3B) activates extrinsic apoptosis during cigarette smoke-induced emphysema. Proc Natl Acad Sci USA 107: 18880-18885, 2010.
93. Yang ZJ, Chee CE, Huang S and Sinicrope FA: The role of autophagy in cancer: Therapeutic implications. Mol Cancer Ther 10: 1533-1541, 2011.
94. Kim EJ, Jeong JH, Bae S, Kang S, Kim CH and Lim YB: mTOR inhibitors radiosensitize PTEN-deficient non-small-cell lung cancer cells harboring an EGFR activating mutation by inducing autophagy. J Cell Biochem 114: 1248-1256, 2013.
95. Hsieh CH, Pai PY, Hsueh HW, Yuan SS and Hsieh YC: Complete induction of autophagy is essential for cardioprotection in sepsis. Ann Surg 253: 1190-1200, 2011.